Additionally, miR-376a regulated the epigenetic modification via targetting HDAC9 in HCC, and HDAC9 inhibited miR-376a by reducing the H3K18Ac modification levels [6]. The gene discussed is HDAC9; the disease is hepatocellular carcinoma.